It will use cognitive computing power to help healthcare providers offer personalised treatment.
IBM Watson Health, which acquired enterprise imaging software firm Merge Healthcare in 2015, is bringing artificial intelligence (AI) to radiology at the Radiological Society of North America Annual Meeting (RSNA 2016).
The company is exhibiting new imaging solutions designed to help healthcare providers carry out personalised approaches to patient diagnosis, treatment, and monitoring.
The solutions is based on its over ten years of machine learning and AI work undertaken in IBM Research.
IBM is previewing seven products at the medical meeting.
Watson Health is exhibiting a cognitive peer review tool to help healthcare professionals reconcile differences between a patient’s clinical evidence, and data in the electronic health record (EHR).
A cognitive data summarization tool aims to provide radiologists, cardiologists, and other physicians with patient-specific clinical data to use when interpreting imaging studies, or while diagnosing and treating patients.
A cognitive physician support tool intends to allow doctors personalise healthcare decisions depending on integrating imaging data with other types of patient information.
Another product, the MedyMatch Brain Bleed app, is a cognitive image review tool which seeks to assist emergency room physicians in diagnosing a stroke or brain bleed in a trauma patient by finding appropriate evidence in a patient record.
Merge Healthcare is showcasing Marktation, a new process for interpreting medical images to help physicians enhance image reading speed and accuracy. It is initially being applied in mammography.
Watson Clinical Integration Module, a cloud application for radiologists intends to help increase reader efficiency and counteract common causes of errors in medical imaging.
Finally, lesion segmentation and tracking module is designed to help radiologists increase the speed by which they interpret and report comparison exams in cancer patients and other conditions that need longitudinal tracking.
IBM Watson Health vice president of imaging Anne LeGrand said: “The breadth and depth of Watson-powered solutions on display at RSNA 2016 from Watson Health’s imaging group and from Merge are unmatched among the AI community, and showcase how IBM is bringing cognitive computing to healthcare in clinically meaningful ways.”